ETF Daily News: Thursday, January 5th ETF Movers (GRN, EU, XBI, CANE, GAZ, EWI)
In trading on Thursday, the iPath Global Carbon ETN (NYSEArca:GRN) is outperforming other ETFs, up about 13.04% on the day. Also up on the day are the Read more…
|
|
In trading on Thursday, the iPath Global Carbon ETN (NYSEArca:GRN) is outperforming other ETFs, up about 13.04% on the day. Also up on the day are the Read more…
Stocks surged higher across the board on Tuesday on strong trade. All five major indices closed well in the black, with large cap issues leading the advance. By the closing bell the Nasdaq (NASDAQ:QQQ), S&P 500 (NYSEARCA:SPY) and the Dow Jones Industrial Average (NYSEARCA:DIA) posted Read more…
In trading on Monday, the iShares Nasdaq Biotechnology (NASDAQ:IBB) is outperforming other ETFs, up about 4.78% on the day. Also up on the day are the Read more…
Ron Rowland: Like many of you, I’m a Baby Boomer. Now I find myself north of 50 and the prospect of getting “old” isn’t very attractive. What does this have to do with investing and ETFs? Plenty! Read more…
IBB, NASDAQ:BIB, NASDAQ:BIS, NYSE:FBT, PBE, XBI
Equities performed well on Thursday pacing all five major indices well into positive territory. By the closing bell the S&P 500 (NYSE:SPY) tacked on 1.4% while the Dow Jones Industrial Average (NYSE:DIA) and small-cap Russell 2000 (NYSE:IWM) followed closely as both gained 1.2% Read more…
David Fry: Our goal in this profile is to help investors wade through the many competing ETF offerings available. Using our long experience as an ETF publication, and nearly 40 years in the investment business, we can help select those ETFs that matter and may or may not be repetitive. Read more…
As the equity markets continue to remain volatile and are highly susceptible to overall investor sentiment, it is important to consider certain sectors which are able to prosper in times of Read more…
On light volume, the major indices ended Friday’s session split. The blue chip Dow ended the year by posting a slim 0.1% gain on the session. The S&P 500 finished the day flat, while the Nasdaq, S&P Read more…
While a number of companies are on the verge of hitting the market with exciting new drug products or medical treatments, the biggest 2011 profits for investors in the biotech stocks are Read more…
Over the past few weeks the biotechnology sector has witnessed a significant uptick in mergers and acquisitions as large cash-heavy biotech companies are looking to diversify and broaden their Read more…
In today’s volatile markets, it’s more important than ever to seek out sectors that have potential to grow regardless of continuing difficult economic conditions. One such sector is biotechnology, Read more…
March was the 10th anniversary of the beginning of the “tech wreck” when the NASDAQ peaked at 5132 on March 10, 2000. As we look back ten years and all that has transpired in technology and Read more…
Most Comments